HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

8-azidoadenosine-3',5'-monophosphate

Also Known As:

8-N3-cAMP; 8-azido-cyclic AMP; 8-azidoadenosine 3',5'-monophosphate

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Neoplasms (Cancer) 06/01/1983 - "Although the average incorporation of 8-N3-cAMP was 0.29 +/- 0.02 (S.E.) pmol/mg protein for control and 0.45 +/- 0.06 pmol/mg protein for neoplastic breast tissue cytosol, this difference does not reflect different cellular concentrations of cAMP receptors since the content of blood protein components is lower in tumor tissue. "
2.	Hepatocellular Carcinoma (Hepatoma) 01/01/1981 - "Incubation of H-35 hepatoma cells with vesicle-8-N3-cAMP resulted in increased TAT activity, preceded by the binding of 8-N3-cAMP to the regulatory subunit of type II cAMP-dependent protein kinase. "

Related Drugs and Biologics

1.	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)
2.	Cyclic AMP Receptors (Cyclic AMP Receptor)
3.	Proteins (Proteins, Gene)
4.	Blood Proteins (Serum Proteins)